Skip to main content
Industry News
Lonza gains Swiss nod to start producing Moderna vaccine
1/4/2021

The Lonza Group has gained the approval of Swiss drug regulator Swissmedic to begin manufacturing Moderna Therapeutics' COVID-19 vaccine at a facility in Switzerland, according to the newspaper SonntagsZeitung. Swissmedic is expected to approve Moderna's COVID-19 vaccine soon following its approval of Pfizer and partner BioNTech's vaccine.

Full Story: